Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Feb 03,2016
Single Cell Lights Beacon to Cancer Origins
    Conundrums exist in every facet of our daily lives and are often dismissed as either general annoyances or fleeting curiosities. Yet for scientists, solving common scientific enigmas can often lead to a watershed moment within their respective discipline.  For instance, researchers have been perplexed for decades as to why the vast number of cells thatRead more
More
Single Cell Lights Beacon to Cancer Origins
Feb 02,2016
Scientists Prune Away Schizophrenia Hidden Genetic Mechanisms
    A new study by researchers at the Broad Institute's Stanley Center for Psychiatric Research, Harvard Medical School, and Boston Children's Hospital genetically analyzed nearly 65,000 people and revealed that an individual's risk of schizophrenia is increased if they inherited distinct variants in a gene related to "synaptic pruning”—the elimination of connections between neurons. This newRead more
More
Scientists Prune Away Schizophrenia Hidden Genetic Mechanisms
Feb 02,2016
Mapping the Mouth Microbiome
    Researchers from the Forsyth Institute and the Marine Biological Laboratory used a novel fluorescence imaging technique and DNA sequencing to create a high-resolution map of the bacteria in dental plaque. The scientists say they can now see where the bacteria are in relation to each other and that gaining new understanding of how the bacteriaRead more
More
Feb 01,2016
Epigenome Tapped to Understand Rise of Subtype of Brain Medulloblastoma
    An international team of scientists say they have identified the cells that likely give rise to the brain tumor subtype Group 4 medulloblastoma. The believe their study ("Active medulloblastoma enhancers reveal subgroup-specific cellular origins”), published in Nature, removes a barrier to developing more effective targeted therapies against the brain tumor's most common subtype.       MedulloblastomaRead more
More
Epigenome Tapped to Understand Rise of Subtype of Brain Medulloblastoma
Feb 01,2016
CRISPR Fixes Stem Cells Harboring Blindness-Causing Defect
Marking yet another CRISPR-related first, scientists have replaced a defective gene associated with a sensory disease in stem cells that were derived from a patient's tissue. The disease, retinitis pigmentosa (RP), is an inherited condition that degrades the retina and leads to blindness. A patient with the disease supplied a skin sample that was usedRead more
More
Jan 29,2016
Projecting Zika Virus Spread and Using Biowarfare as a Countermeasure
    If you've been paying attention to the news over the past several weeks, you may have noticed, among the political rabble and international exchanges that a peculiarly named viral infection is beginning to emerge and spread rapidly across the globe.     In early October, a team of scientists at the University of Wisconsin–Madison and Universidad deRead more
More
Projecting Zika Virus Spread and Using Biowarfare as a Countermeasure
Jan 29,2016
New Drug Kicks the Cancer Stem Cell Addiction
    A major obstacle thwarting cancer treatment is being able to identify and eliminate all of the cancer cells, in particular, the few that retain the capacity to create an entire tumor. These so-called cancer stem cells not only have the ability to regenerate the tumor after therapeutic intervention, but they can also migrate to variousRead more
More
Jan 28,2016
Nanoparticles Deliver Therapeutics to Diseased Livers
    UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.       The dendrimer nanoparticles were able to exert their effect without further damaging the liver or neighboring tissue, according to the researchers who published their findingsRead more
More
Jan 28,2016
Researchers Develop Fast Testing Method for Antibiotic Susceptibility
    Researchers from the University of California, San Diego have developed a speedy method to determine whether bacteria are susceptible to antibiotics, potentially slowing the emergence of drug resistance among patients, a new report said.     In a paper (“Bacterial Cytological Profiling as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus”) published in EBioMedicine,Read more
More
Jan 27,2016
Novel Biomarker for the Prediction in Metastatic Cancer
    Identifying the appropriate genetic sequences to accurately predict the onset or progression of disease is considered as the center of biomarker technology. These gene targets are especially significant for the diagnosis and tracking of various cancers, and scientists are always on the hunt to discover better prognostic biomarkers to give them an edge in combatingRead more
More
Novel Biomarker for the Prediction in Metastatic Cancer
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->